Ambeed.cn

首页 / / / / Methylthiouracil/甲基硫脲嘧啶

Methylthiouracil/甲基硫脲嘧啶 {[allProObj[0].p_purity_real_show]}

货号:A215834 同义名: 甲硫氧嘧啶 / MTU

Methylthiouracil 是一种抗甲状腺化合物,作用是减少储存的甲状腺激素(如甲状腺球蛋白)在甲状腺中的形成。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Methylthiouracil/甲基硫脲嘧啶 化学结构 CAS号:56-04-2
Methylthiouracil/甲基硫脲嘧啶 化学结构
CAS号:56-04-2
Methylthiouracil/甲基硫脲嘧啶 3D分子结构
CAS号:56-04-2
Methylthiouracil/甲基硫脲嘧啶 化学结构 CAS号:56-04-2
Methylthiouracil/甲基硫脲嘧啶 3D分子结构 CAS号:56-04-2
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Methylthiouracil/甲基硫脲嘧啶 纯度/质量文件 产品仅供科研

货号:A215834 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Methylthiouracil/甲基硫脲嘧啶 生物活性

描述 Human Umbilical Vein Endothelial Cells (HUVECs) are exposed to various concentrations of Methylthiouracil (MTU), ranging from 0 to 20 μM, for six hours following an initial treatment with LPS (100 ng/mL) for four hours. MTU effectively reduces LPS-induced hyperpermeability in these endothelial cells, showing maximal efficacy at concentrations exceeding 5 μM. Additionally, subsequent treatment with MTU at 10 or 20 μM suppresses the formation of LPS-induced paracellular gaps while promoting the development of dense F-actin rings. To evaluate MTU's safety, cellular viability assays are conducted on HUVECs treated with MTU for 24 hours, confirming that MTU up to 20 μM does not compromise cell viability[1].
体内研究

Methylthiouracil is also utilized in animal models to study cardiovascular and cerebrovascular diseases. Specifically, MTU treatment significantly reduces the peritoneal leakage of dye triggered by LPS. Given that the average circulating blood volume in mice is 72 mL/kg and the average weight of the mice used in this study is 27 g, with an estimated blood volume of 2 mL, the administration of MTU at doses of 142 or 284 μg/kg achieves a maximum concentration of 10 or 20 μM in the peripheral blood[1].

体外研究

Human Umbilical Vein Endothelial Cells (HUVECs) are exposed to various concentrations of Methylthiouracil (MTU), ranging from 0 to 20 μM, for six hours following an initial treatment with LPS (100 ng/mL) for four hours. MTU effectively reduces LPS-induced hyperpermeability in these endothelial cells, showing maximal efficacy at concentrations exceeding 5 μM. Additionally, subsequent treatment with MTU at 10 or 20 μM suppresses the formation of LPS-induced paracellular gaps while promoting the development of dense F-actin rings. To evaluate MTU's safety, cellular viability assays are conducted on HUVECs treated with MTU for 24 hours, confirming that MTU up to 20 μM does not compromise cell viability[1].

Methylthiouracil/甲基硫脲嘧啶 细胞实验

Cell Line
Concentration Treated Time Description References
Human umbilical vein endothelial cells (HUVECs) 0-20 μM 6 hrs MTU suppressed PolyP-mediated vascular barrier permeability J Cell Mol Med. 2016 Dec;20(12):2333-2340
B16F10 cells 266 μM(IC50) 48 hours Evaluate the effect of Methylthiouracil on melanin content, showing no cytotoxicity at 20 μM but no significant reduction in melanin content. Int J Mol Sci. 2015 Dec 2;16(12):28534-48
rat bone marrow stromal cells 10, 20, 40, 80, 160, 320 mmol/l 48 hours To investigate the effect of MTU on BMSC apoptosis. Results showed that MTU promoted BMSC apoptosis, and the apoptosis rate increased with increasing concentration. Exp Ther Med. 2014 Jun;7(6):1738-1744

Methylthiouracil/甲基硫脲嘧啶 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Wistar-Kyoto rats Atherosclerosis model induced by cholesterol-rich diet plus methylthiouracil Gavage 80 mg/kg/day Once daily for five months To investigate the role of methylthiouracil in a cholesterol-rich diet-induced atherosclerosis model. Results showed that cholesterol-rich diet plus methylthiouracil led to lipid deposition, VSMC proliferation, and migration toward intima in aortic tissues, which were significantly alleviated by rosiglitazone treatment. Cardiovasc Diabetol. 2011 Jan 26;10:10
C57BL/6 mice PolyP-induced vascular inflammatory model Intravenous injection 28-284 μg/kg Single or twice administration (at 12 hrs and 50 hrs post-PolyP) MTU suppressed PolyP-mediated vascular permeability and leucocyte migration, increased survival rate, and reduced hepatic and renal injury markers J Cell Mol Med. 2016 Dec;20(12):2333-2340
Rat Congenital hypothyroidism model Oral 0.1%(drinking water) From gestation day 16 until sacrifice postnatally To study the effect of thyroid hormone on microglial development, results showed hypothyroidism led to reduced microglial cell numbers and processes. J Neurosci. 2001 Mar 15;21(6):2028-38
Rats Normal rats Subcutaneous injection 0.02g Daily for seven days To assess the inhibitory effect of methylthiouracil on thyroid activity. Results showed that follicular cells possessed more numerous and larger microvilli (up to 2.0 μm), dilated cisternae of endoplasmic reticulum, elongated mitochondria (up to 2.3 μm), and more oval or indented nuclei. J Anat. 1982 Sep;135(Pt 2):407-12
Rats Intact and castrate rats Drinking water 20mg/day Continuous administration Methylthiouracil accelerates and increases the induction of cervico-vaginal sarcomas and epithelial tumours in both intact and castrate rats. Br J Cancer. 1970 Sep;24(3):510-27
Rats Castrate rats Drinking water 20mg/day Continuous administration Methylthiouracil lowers the threshold for basal celled vulval neoplasms and promotes the formation of basal celled vulval tumours. Br J Cancer. 1970 Dec;24(4):769-84

Methylthiouracil/甲基硫脲嘧啶 参考文献

[1]Ku SK, et al. Anti-inflammatory effects of methylthiouracil in vitro and in vivo. Toxicol Appl Pharmacol. 2015 Nov 1;288(3):374-86.

Methylthiouracil/甲基硫脲嘧啶 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

7.03mL

1.41mL

0.70mL

35.17mL

7.03mL

3.52mL

70.33mL

14.07mL

7.03mL

Methylthiouracil/甲基硫脲嘧啶 技术信息

CAS号56-04-2
分子式C5H6N2OS
分子量 142.18
SMILES Code O=C(C=C(C)N1)NC1=S
MDL No. MFCD00006040
别名 甲硫氧嘧啶 ;MTU
运输蓝冰
InChI Key HWGBHCRJGXAGEU-UHFFFAOYSA-N
Pubchem ID 667493
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Keep in dark place, sealed in dry, room temperature

溶解方案

DMSO: 50 mg/mL(351.67 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。